Understanding Chai Hu Jia Long Gu Mu Li Tang
We investigated the protective effects of the traditional
Japanese herbal medicine Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang
in Chinese) (SRBT) against hypercholesterolemia and atherosclerotic lesions. We
focused on atherosclerosis using female heterozygous Kurosawa and
Kusanagi-hypercholesterolemic (KHC) rabbits. The total plasma cholesterol
levels increased for up to 12 weeks after beginning a diet containing 0.1%
cholesterol and then reached a plateau of about 600 mg dl(-1). When SRBT was
administered at a dose of 1.0 g kg(-1)per day for 24 weeks, total plasma
cholesterol levels were significantly decreased after 20-24 weeks. On the other
hand, pravastatin at a dose of 10 mg kg(-1)per day produced a significant
decrease in total plasma cholesterol levels from 4 to 24 weeks (about 105-130
mg dl(-1)). Moreover, 1.0 g kg(-1)per day of SRBT significantly decreased
plasma low density lipoprotein (LDL) cholesterol levels but did not change
either very low density lipoprotein (VLDL), or high density lipoprotein (HDL)
cholesterol levels. Animals that received pravastatin had significantly
decreased LDL cholesterol levels and VLDL cholesterol levels after 8 weeks and
at 24 weeks. We also examined the expression of apoB, E and LDL receptor mRNA
levels in the liver at 24 weeks after beginning the administration of 1.0 g
kg(-1)per day of SRBT. Both apoE and LDL receptor mRNA levels were
significantly increased compared with those in rabbits receiving the 0.1%
cholesterol diet. SRBT at a dose of 1.0 g kg(-1)per day significantly depressed
the intimal surface area of the thoracic aortae involved with atheromatous
plaques. The present results suggest that SRBT may protect against
hypercholesterolemia and atheromatous lesions by affecting apoE and LDL
receptor mRNA gene expression in the liver.
Source: Yoshie F,
Iizuka A,
Kubo M,
Komatsu Y,
Matsumoto A,
Itakura H,
Takeda H,
Matsumiya T,
Kondo K.
Protective
effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against
atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.
Pharmacol
Res. 2001 May;43(5):481-8.
No comments:
Post a Comment